A Prospective Multicenter Post Approval Study of the ReShape™ Integrated Dual Balloon System in Obese Subjects
NCT02927665 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 186
Last updated 2019-03-29
Summary
The ReShape Post Approval Study is a prospective multicenter study of the ReShape(TM) Integrated Dual Balloon System in Obese Subjects.
Conditions
Interventions
- DEVICE
-
Reshape Integrated Dual Balloon
Sponsors & Collaborators
-
ReShape Lifesciences
lead INDUSTRY
Principal Investigators
-
Scott Shikora · ReShape Lifesciences
Eligibility
- Min Age
- 22 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-09-30
- Primary Completion
- 2019-11-30
- Completion
- 2019-12-31
Countries
- United States
Study Locations
More Related Trials
-
Obalon US Commercial Registry
NCT03688256 ·Status: COMPLETED
-
Safety and Effectiveness of Orbera365™ Intragastric Balloon System
NCT07062094 ·Status: RECRUITING
-
Orbera365 Intragastric Balloon System (Abbreviated as'Orbera365')
NCT07195708 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
ENDObesity® II Study: TransPyloric Shuttle® System for Weight Loss
NCT02518685 ·Status: COMPLETED ·Phase: NA
-
Evaluation of a 6-month Intragastric Balloon
NCT06585371 ·Status: NOT_YET_RECRUITING
-
A Study of BioEnterics® Intragastric Balloon (BIB®) System to Assist in the Weight Management of Obese Subjects
NCT00730327 ·Status: COMPLETED ·Phase: NA
-
THE ENLIGHTEN STUDY
NCT03261453 ·Status: COMPLETED ·Phase: NA
-
Fat Reduction in the Flanks Area vs. Control
NCT02465775 ·Status: UNKNOWN ·Phase: NA
-
Intragastric Balloon, Air Versus Fluid Filled: Randomized Prospective Study
NCT02129296 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Intragastric Balloon With Lifestyle Intervention vs. Lifestyle Intervention in Obese Patients With NASH
NCT03538236 ·Status: WITHDRAWN ·Phase: NA
-
Procedure for Duodenal-Ileal Diversion With a Sleeve Gastrectomy for Patients With Obesity and Type 2 Diabetes Mellitus
NCT04627103 ·Status: COMPLETED ·Phase: NA
-
ReShape Vest™ for the Treatment of Obesity (Europe)
NCT03918564 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Optimization and Follow-up of the Consecutive Use of Two Intragastric Balloons in the Treatment of Obesity
NCT03102697 ·Status: COMPLETED
-
Clinical Study to Evaluate the Safety and Efficacy of the UltraShape Device for Non-Invasive Abdominal Fat Reduction
NCT02700152 ·Status: UNKNOWN ·Phase: NA
-
Spatz3 Adjustable Balloon System® (Spatz3) Post Approval Study
NCT05086302 ·Status: COMPLETED
-
Outcome of Combined Botulinum Toxin A Injection and Gastric Balloon Implantation in Obesity Treatment
NCT05872932 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
An Open-Label Study to Evaluate Retreatment With LIPO-202
NCT02397525 ·Status: UNKNOWN ·Phase: PHASE2
-
Pilot Trial of the Elipse™ Intragastric Balloon System for the Treatment of Overweight and Obese Individuals
NCT02802007 ·Status: UNKNOWN ·Phase: NA
-
Gastric Ultrasound in Patients Who Have Undergone Bariatric Surgery
NCT07310875 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Lowering Weight in Severe Obesity by Embolization of the Gastric Artery Trial
NCT03185949 ·Status: COMPLETED ·Phase: NA
-
The BALLOON- (BALLOon Treatment for Obesity in Norway) Pilot Study
NCT03576833 ·Status: UNKNOWN ·Phase: NA
-
SlimShape Device for Abdominal Fat and Circumference Reduction
NCT02999763 ·Status: COMPLETED ·Phase: NA
-
Pilot Study to Evaluate A Novel Gastric Space Occupying Device
NCT01444274 ·Status: COMPLETED
-
Study to Evaluate Novel Gastric Space Occupying Device
NCT01288456 ·Status: COMPLETED
-
UltraShape Power for Abdominal Fat and Circumference Reduction
NCT02748928 ·Status: COMPLETED ·Phase: NA